BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica…
FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace
FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace
Agreement covers employees who agree to leave voluntarily. Source: BioSpace
Takeda CEO Christophe Weber is sticking to his game plan of actively hunting deals that will expand its global presence and create a stronger international profile. Source: BioSpace
Kala Pharma released mostly positive topline results from two Phase III clinical trials for KPI-121 in patients with dry eye disease. Source: BioSpace
Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion. Source: BioSpace
Shares of TiGenix shot up more than 72 percent in pre-market trading after the deal was announced. Source: BioSpace
The company will undergo a reorganization that includes the termination of a number of sales representatives. Source: BioSpace
The additional capital is expected to provide funding to advance avacopan through topline data from the Phase III ADVOCATE trial as well as potential registration filings in the U.S. and…
The Series A round was entirely funded by founding investor Apple Tree Partners. Source: BioSpace
Dr. Lammers brings more than 27 years of experience in product and clinical development spanning the pharmaceutical and biotechnology industries. Source: BioSpace